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Abstract
Background: The Sec-dependent protein export apparatus of Escherichia coli is very efficient at
correctly identifying proteins to be exported from the cytoplasm. Even bacterial strains that carry
prl mutations, which allow export of signal sequence-defective precursors, accurately differentiate
between cytoplasmic and mutant secretory proteins. It was proposed previously that the basis for
this precise discrimination is the slow folding rate of secretory proteins, resulting in binding by the
secretory chaperone, SecB, and subsequent targeting to translocase. Based on this proposal, we
hypothesized that a cytoplasmic protein containing a mutation that slows its rate of folding would
be recognized by SecB and therefore targeted to the Sec pathway. In a Prl suppressor strain the
mutant protein would be exported to the periplasm due to loss of ability to reject non-secretory
proteins from the pathway.
Results: In the current work, we tested this hypothesis using a mutant form of λ repressor that
folds slowly. No export of the mutant protein was observed, even in a prl strain. We then examined
binding of the mutant λ repressor to SecB. We did not observe interaction by either of two assays,
indicating that slow folding is not sufficient for SecB binding and targeting to translocase.
Conclusions: These results strongly suggest that to be targeted to the export pathway, secretory
proteins contain signals in addition to the canonical signal sequence and the rate of folding.
Background
The Sec-dependent protein export pathway of Escherichia
coli is responsible for translocation of secretory proteins
across the inner membrane to final destinations in the
periplasm or outer membrane. Secretory proteins, also
called preproteins, are synthesized with a cleavable amino
terminal signal sequence that functions both to slow fold-
ing of the preprotein and to aid in recognition of the se-
cretory protein by export factors. Export of many, but not
all, secretory proteins is dependent on interaction with
SecB, a cytoplasmic chaperone that maintains the prepro-
tein in a loosely folded conformation competent for trans-
location. Both SecB and the preprotein provide binding
sites for SecA, a peripheral membrane ATPase. SecA targets
the preprotein to the membranous translocase complex
composed of SecY, SecE, SecG, SecD, SecF, and YajC. For-
mation of the complete translocase complex promotes an
ATP binding and hydrolysis cycle by SecA that results in
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segmental translocation of the secretory protein across the
membrane [1–4].
The signal sequence is crucial for efficient translocation;
mutations in the signal sequence significantly reduce ex-
port of the preprotein and complete deletions of the sig-
nal sequence eliminate essentially all export [5–8].
Selection for extragenic suppressors of such export defec-
tive preproteins led to the identification of the prl alleles
of secY (prlA), secE (prlG), secA (prlD), and more recently
secG (prlH) [6,9–11]. Early hypotheses predicted that the
Prl suppressors function by expanded or altered interac-
tions with signal sequences, facilitating recognition of
mutant as well as wild type signal sequences [6].
More recent observations support an alternative mecha-
nism of action for the PrlA/SecY and PrlG/SecE suppres-
sors [8,12]. First, PrlA/G-mediated suppression does not
exhibit allele specificity; all prlA and all prlG alleles that
have been examined suppress all signal sequence muta-
tions, implying that suppression is not due to a specific al-
tered interaction that allows recognition of a mutant
signal sequence [8,12]. Furthermore, all of the prlA and
prlG alleles suppress complete deletions of the signal se-
quence, suggesting that an interaction between the signal
sequence and the Prl suppressor is not necessary for sup-
pression or even for export [5,8,13]. Based on these obser-
vations, it was proposed that the PrlA and PrlG
suppressors do not function through altered interactions
with signal sequences, but rather by loss of recognition
[8,12]. The wild type SecE and SecY proteins are thought
to function in concert to proofread the signal sequence of
secretory proteins, rejecting defective precursors from the
export pathway. The PrlA (SecY) and PrlG (SecE) suppres-
sors are compromised in their ability to proofread, allow-
ing export of proteins with mutations, or even complete
deletions, of the signal sequence.
This proofreading model predicts that the critical step for
translocation of a signal sequence-defective secretory pro-
tein is recognition by SecB and subsequent presentation
to SecE/Y. SecB binds portions of the mature secretory
protein [14–18], and SecA would bind to the SecB-precur-
sor complex by virtue of its ability to bind SecB [19,20] as
well as the preprotein [21–23]. Thus, SecA-mediated tar-
geting of the preprotein to translocase would occur. In a
wild type cell, the mutant precursor would be rejected at
this point by SecY/E, but in a PrlA or PrlG suppressor
strain, rejection would not occur and the mutant secretory
protein would be exported.
In fact, all of the PrlA and PrlG suppressors are completely
dependent on functional SecB for manifestation of sup-
pressor activity [5,8]. Even certain proteins that are not
normally SecB-dependent for translocation become SecB-
dependent when they contain a signal sequence mutation
and are exported via the suppressor pathway. For exam-
ple, PhoA is normally exported independent of SecB. De-
letion of the signal sequence from phoA severely
compromises export; export is restored in a prlA suppres-
sor strain. However, this suppression is dependent on
SecB [5]. Therefore, there are characteristics of the mature
portion of PhoA that promote recognition by SecB, and
this recognition is essential for PrlA-mediated suppres-
sion.
Although prlA and prlG strains export secretory proteins
that completely lack a signal sequence, there is no evi-
dence of export of any cytoplasmic proteins in a prl sup-
pressor strain [13]. That is, proteins that are supposed to
remain in the cytoplasm are not mislocalized to the peri-
plasm. It has been suggested that perhaps cytoplasmic
proteins are not exported in prl suppressor strains because
they fold rapidly and escape recognition by SecB, while se-
cretory proteins, even those lacking a signal sequence, fold
more slowly, allowing time for SecB recognition and
binding [5,13]. SecB binds to a variety of unfolded pro-
teins in vitro [24,25], although binding appears to be
more selective in vivo [26]. This selectivity may be based
on the slower folding characteristics of secretory proteins.
Therefore, we proposed previously that if a cytoplasmic
protein contains a mutation that slows its rate of folding,
SecB will recognize and bind to that mutant protein. Bind-
ing of SecB would result in targeting of the unfolded pro-
tein to the translocation apparatus. According to the
proofreading model, in a wild type strain, SecE and SecY
would reject the unfolded protein due to lack of a signal
sequence. In a Prl suppressor strain, however, the proof-
reading function would be compromised and the mutant
protein would be exported [8]. In the experiments de-
scribed here, we tested this hypothesis by examining the
export of such a cytoplasmic protein with a folding muta-
tion. The results indicate that slow folding is not sufficient
for SecB binding and subsequent targeting to translocase
and further, that secretory proteins contain targeting in-
formation in addition to the signal sequence and the fold-
ing kinetics.
Results and Discussion
To test the hypothesis that a cytoplasmic protein contain-
ing a mutation that slowed its folding would be exported
in a Prl suppressor strain, a well characterized cytoplasmic
protein was obtained. The protein of choice was the ami-
no terminal portion of the λ repressor protein, a 92 resi-
due domain that folds into a stable, predominantly α-
helical structure [27]. Folding studies were performed at a
pH and ionic strength similar to physiological conditions
and the folding parameters were predicted to approximate
the in vivo situation. The wild type protein (N102LT) isBMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/32
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very stable at 37°C, with a Tm for unfolding of about
55°C. The mutant version that we used (LA57-N102LT)
contains a Leu to Ala alteration of amino acid 57 that dra-
matically reduces the stability of the folded structure. The
LA57-N102LT protein has a Tm of approximately 25°C, and
is about 80% unfolded at 37°C and 60% unfolded at 30°C
[27]. Further, the mutant protein has been shown to have
a half-life of about 40 minutes in wild type E. coli strains
at 37°C [27].
Localization of N102LT and LA57-N102LT
Plasmids pKL106 and pKL107 encoding LA57-N102LT-
FLAG or N102LT-FLAG, respectively, were transformed
into strains IM104 (wild type secY) or IM105 (prlA4).
These strains contained deletion mutations in the lon and
degP genes to limit proteolysis in both the cytoplasmic
and periplasmic spaces. Following induction of the λ re-
pressor fragment, whole cell lysates, spheroplasts, and
periplasmic fractions were prepared from each strain.
Samples were analyzed by Western blotting using anti-
bodies directed against the FLAG epitope present at the
carboxyl terminus of the λ repressor fragments.
According to our hypothesis, the largely unfolded nature
of LA57-N102LT should allow SecB to bind, resulting in
targeting of LA57-N102LT to translocase. In the secY wild
type strain, proofreading by SecE/Y would block export of
LA57-N102LT, while in the prlA4 strain, the PrlA4 suppres-
sor would allow export of a portion of LA57-N102LT to the
periplasm. This was not the result we observed (Fig. 1).
No LA57-N102LT was detected in the periplasm, even in
the prlA4 strain, indicating that export did not occur to
any significant extent. To ensure that all periplasmic con-
tents were released during the spheroplast preparation,
the blots were stripped of FLAG antibody and reprobed
with antibody directed against MalE, a periplasmic bind-
ing protein. All detectable MalE was present in the peri-
plasmic fractions (data not shown), demonstrating that
complete release of the periplasmic contents had been at-
tained. Therefore, there was no detectable export of LA57-
N102LT in the prlA4 strain.
There were two reasonable explanations for this unexpect-
ed finding; 1) an unfolded state is not sufficient for SecB
binding, or 2) SecB binding is not sufficient to promote
export in a prl suppressor strain. To distinguish between
these possibilities, we examined whether SecB was able to
bind LA57-N102LT using two different methods to identify
interactions. The first approach was co-immunoprecipita-
tion of LA57-N102LT-SecB complexes, the second was an
in vitro protease protection assay.
Co-immunoprecipitation of SecB complexes
Co-immunoprecipitations were performed using whole
cell lysates of strains induced for expression of λ repressor.
Immunoprecipitations were performed as described using
antibodies directed either against SecB or against the His
tag on the λ repressor. Following the immunoprecipita-
tion reaction, samples were analyzed by Western blotting
using the opposite antibody, that is, samples that had
been immunoprecipitated with anti-SecB were examined
with anti-His while those that had been precipitated with
anti-His were probed with anti-SecB. In addition, as a pos-
itive control, the interaction of SecB with the secretory
protein LamB was examined using anti-LamB antibodies.
While an interaction between LamB and SecB was clearly
seen (Fig. 2c), no interaction was observed between SecB
and either N102LT or LA57-N102LT (Fig. 2a and 2b). This
was true regardless of whether the precipitating antibody
was directed against SecB or the His tag. The wild type
N102LT was not expected to interact with SecB as it would
fold very rapidly and stably; it was more surprising that no
interaction was detected between SecB and the destabi-
lized LA57-N102LT. This result implied that the unfolded
nature of LA57-N102LT was not sufficient for SecB binding.
Protease protection assays
To substantiate the results observed by co-immunoprecip-
itation, an in vitro protease protection assay was em-
ployed. SecB has a proteolytic-sensitive domain that is
cleaved by proteinase K in a limited proteolysis reaction.
When substrate is bound to SecB, the conformation is al-
Figure 1
Immunodetection of λ repressor fragments in bacte-
rial fractions LA57 indicates the slow folding λ repressor,
LA57-N102LT, while wt refers to the wild type λ repressor,
N102LT. The strains used were either wild type secY/prlA or
prlA4 as indicated. The individual lanes are as follows: M –
purified N102LT used as a molecular weight marker, W –
whole cell lysate, S – spheroplast fraction (containing cyto-
plasmic contents and membranes), P – periplasmic fraction.BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/32
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tered such that the site is no longer protease accessible,
rendering SecB protease resistant [28]. Thus, this assay can
be used to detect binding of SecB to a substrate. Poly-L-
lysine and small peptides are routinely used as substrates
for this analysis as demonstrated in Fig. 3 (lanes 3 and 4).
To determine whether a larger protein was also able to
protect SecB, we used purified, urea-denatured proOmpA
as a substrate. The proOmpA also was able to bind to and
protect SecB (Fig. 3, lanes 9 and 10) although a much
higher concentration of substrate was required to achieve
50% protection. To ensure that the observed protection
was not due simply to the high protein concentration in
the reaction, a non-secretory protein was used as a nega-
tive control. BSA was added to the same concentration or
higher as proOmpA with no resultant protection of SecB
(data not shown). Therefore, this assay reliably serves as
an additional method to observe SecB-substrate interac-
tions.
The λ repressor proteins were purified on a nickel affinity
chromatography column by virtue of the His tag at the
carboxyl terminus of the proteins. Each was assayed for
protection of SecB at concentrations up to and exceeding
that used for proOmpA. Neither N102LT nor LA57-N102LT
protected SecB from proteolysis, indicating that no bind-
ing occurred (Fig. 3, lanes 5–8). Although the mutant
LA57-N102LT is predicted to be in an unfolded conforma-
tion in the bacterial cell, the protease protection assay was
performed at 4°C. To verify that refolding of LA57-N102LT
at this temperature was not interfering with interpretation
of the results, we further tested the SecB binding activity
by incubating LA57-N102LT in 8 M urea, then diluting it
into the protection reaction, similar to the conditions
used for proOmpA. Again, no protection was detected
(data not shown). These results demonstrated that even
when fully unfolded, LA57-N102LT was not a substrate for
SecB binding.
Conclusions
The hypothesis driving the present studies was premised
on the observation that prl suppressor strains are able to
correctly identify secretory proteins, even in the absence of
a signal sequence. It has been widely thought that this rec-
ognition was due to slow folding of secretory proteins in
the cytoplasm, resulting in binding by SecB and subse-
quent targeting to translocase. While slow folding may be
a necessary criterion for export, the data presented here in-
dicate that an unfolded nature is not sufficient for SecB
binding and targeting. This conclusion is based on failure
of the LA57-N102LT protein to bind SecB either in vivo or
in vitro. The in vivo results are founded both on the co-
immunoprecipitation experiments and on the fact that no
export of the protein was detected in a prlA4 strain, while
the in vitro results are based on the protease protection as-
says. Therefore, we conclude that secretory proteins must
contain information, in addition to the signal sequence
and slow folding characteristics, that targets them to the
Figure 2
Immunoprecipitations of SecB complexes A. Precipita-
tion was performed with antibody directed against SecB, fol-
lowed by immunoblotting using antibody against the His tag
on the λ repressor fragments. B. Precipitating antibody was
directed against the His tag, immunoblotting utilized the anti-
SecB antibody. C. Precipitation was carried out with antibody
against LamB, anti-SecB was used for immunoblotting. In all
gels, samples were as follows: lanes 1–4 – whole cell lysates
prior to immunoprecipitation, lanes 5–8 – immunoprecipi-
tated material; lanes 1 and 5 – N102LT/prlA4, lanes 2 and 6 –
LA57-N102LT/prlA4, lanes 3 and 7 – N102LT/prlA+, lanes 4 and
8 – LA57-N102LT/prlA+, lane 9 in gel B – purified SecB.
Figure 3
Protease protection assays Lane 1 – undigested SecB,
lane 2 – SecB digested with proteinase K; lanes 3 through 10
– SecB was incubated with potential substrates at the indi-
cated concentrations prior to proteinase K digestion; lane 3
– 20 nM poly-L-lysine, lane 4 – 150 nM poly-L-lysine; lane 5 –
150 nM N102LT (wild type), lane 6 – 4 µM N102LT; lane 7 –
150 nM LA57-N102LT (slow folding mutant), lane 8 – 4 µM
LA57-N102LT; lane 9 – 150 nM proOmpA, lane 10 – 1.4 µM
proOmpA; lane 11 – proOmpA alone digested with protein-
ase K. Lower molecular weight band in lanes 6 and 8 is the λ
repressor fragment.BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/32
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secretory pathway or that cytoplasmic proteins contain in-
formation that prevents export even if the folding param-
eters are altered. Further studies are underway to identify
such targeting sequences.
Methods
Bacterial strains and plasmids
All bacterial strains used were derivatives of E. coli K12
strain MC4100 [29]. IM104 is MC4100 lamB14D
lon::Tn10 degP::kan and IM105 is IM104 prlA4. Plasmids
pKL106 and pKL107 are pET11c (Novagen) derivatives
carrying tandem copies of the λ repressor fragment (de-
rived from plasmids pAD103 and pAD105, generous gifts
from Alan Davidson, University of Toronto and Robert
Sauer, MIT). In pKL106, the wild type λ repressor is tagged
with the myc epitope and the LA57 λ repressor has the
FLAG epitope. In pKL107, the wild type λ repressor con-
tains the FLAG eiptope and the LA57 mutant has the myc
epitope. In all experiments, only antibodies to the FLAG
epitope were used, therefore pKL106 resulted in detection
of the mutant λ repressor and pKL107 was used to observe
the wild type. Plasmids pIM101 and pIM102 were used in
the co-immunoprecipitation assays and for purification of
the λ repressor fragments. These plasmids are derivatives
of pET11c that contain a single copy of the λ repressor, ei-
ther wild type (pIM102) or LA57 (pIM101). The λ repres-
sor inserts contain a FLAG tag at the carboxyl terminus
followed by a hexahistidine motif.
Bacterial growth, induction and fractionations
Plasmid-containing bacteria were grown in LB [30] with
ampicillin (100 µg ml-1) at 30°C. Cells were induced for
expression of the λ repressors at an OD600 = 0.4–0.5 by
addition of 1 mM IPTG either for 30 minutes (spheroplast
procedures) or for 3 hours (immunoprecipitation experi-
ments).
Spheroplasts were prepared similarly to published proto-
cols [31]. Briefly, 1 ml of bacterial cells was pelleted for 3
min at 16,000 rpm in an Eppendorf centrifuge. All subse-
quent steps were performed on ice. The cell pellet was re-
suspended in 0.5 ml spheroplast buffer [1 M sucrose, 25
mM TrisHCl (pH 8.0), 5 mM EDTA, and lysozyme (50 µg
ml-1)]. After incubation on ice for 12 min, MgCl2 was add-
ed to a final concentration of 3 mM and incubation con-
tinued for an additional 5 min. The spheroplasts were
pelleted by centrifugation at 16,000 rpm for 10 min at
4°C. The resultant supernatant contained the periplasmic
contents. The pellet, which consisted of the membranes
and cytoplasmic contents, was resuspended in 0.5 ml of
spheroplast buffer. A parallel sample was prepared with-
out the final centrifugation step, resulting in a whole cell
lysate. All samples were precipitated with TCA and resus-
pended in gel loading buffer preparatory to electrophore-
sis.
Immunoblotting
Fractions were electrophoresed on 17% polyacrylamide
gels and transferred to nitrocellulose. Immunoblotting
was performed as described [32] using monoclonal anti-
body M2 directed against the FLAG epitope (Eastman Ko-
dak) at a 1:600 dilution, or monoclonal antibody against
MalE (Sigma) at a 1:500 dilution. When necessary, anti-
bodies were stripped from the nitrocellulose by incuba-
tion in stripping buffer [1 M glycine (pH 2.2), 20 mM
MgAc, 50 mM KCl] followed by immunoblot blocking so-
lution.
Immunoprecipitations
Bacterial cells were induced for 3 hours for λ repressor ex-
pression as described above and harvested by French Press
lysis. Lysates were immunoprecipitated with minor alter-
ations to previous protocols [8]. Specifically, the IP buffer
contained only 50 mM NaCl and incubation with the pri-
mary antibody was performed overnight at 4°C. Antibod-
ies used were directed against the His epitope
(monoclonal, Boehringer Mannheim), SecB (polyclonal,
gift from William Wickner), or LamB (polyclonal, gift of
Thomas Silhavy). Immune complexes were collected with
Protein A agarose (Pierce), samples were electrophoresed
on 15% polyacrylamide gels, and immunoblotting per-
formed as described above. Following immunodetection,
all blots were stripped of primary antibody and reprobed
with the precipitating antibody to verify that precipitation
had occurred.
Protease protection assays
SecB protease protection assays were performed as de-
scribed [28], followed by electrophoresis on 15% polyacr-
ylamide gels and detection by Coomassie Blue staining.
The λ repressor fragments were purified by nickel NTA af-
finity chromatography (Qiagen).
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